# Greenbrier Companies Inc: financial statements, quarterly

GBX · NYSE · CIK 923120 · [Industrials](/sectors/industrials.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/gbx.md) · [Financials](/companies/gbx/financials.md) · [Filings](/companies/gbx/filings.md) · [Insiders](/companies/gbx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gbx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | Q4 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [809](/filings/0000950170-25-003839.md) | [863](/filings/0000950170-25-052054.md) | [820](/filings/0000950170-25-092942.md) | [1,053 d](/filings/0001193125-26-431954.md) | [876](/filings/0001193125-26-007768.md) | [762](/filings/0001193125-26-145619.md) | [843](/filings/0001193125-26-292719.md) | [760 d](/filings/0001193125-26-431954.md) | [706](/filings/0001193125-26-007768.md) | [588](/filings/0001193125-26-145619.md) | [577](/filings/0001193125-26-292719.md) | [591 d](/filings/0001193125-26-431954.md) |
| Cost of revenue | $m | [688](/filings/0000950170-25-003839.md) | [741](/filings/0000950170-25-052054.md) | [696](/filings/0000950170-25-092942.md) | [862 d](/filings/0001193125-26-431954.md) | [702](/filings/0001193125-26-007768.md) | [624](/filings/0001193125-26-145619.md) | [691](/filings/0001193125-26-292719.md) | [616 d](/filings/0001193125-26-431954.md) | [603](/filings/0001193125-26-007768.md) | [518](/filings/0001193125-26-145619.md) | [495](/filings/0001193125-26-292719.md) | [511 d](/filings/0001193125-26-431954.md) |
| Gross profit | $m | [121](/filings/0000950170-25-003839.md) | [122](/filings/0000950170-25-052054.md) | [124](/filings/0000950170-25-092942.md) | [191 d](/filings/0001193125-26-431954.md) | [174](/filings/0001193125-26-007768.md) | [139](/filings/0001193125-26-145619.md) | [152](/filings/0001193125-26-292719.md) | [144 d](/filings/0001193125-26-431954.md) | [103](/filings/0001193125-26-007768.md) | [69.5](/filings/0001193125-26-145619.md) | [81.1](/filings/0001193125-26-292719.md) | [79.8 d](/filings/0001193125-26-431954.md) |
| Selling, general and administrative | $m | [56.3](/filings/0000950170-25-003839.md) | [63.6](/filings/0000950170-25-052054.md) | [59.3](/filings/0000950170-25-092942.md) | [67.9 d](/filings/0001193125-26-431954.md) | [62.0](/filings/0001193125-26-007768.md) | [64.6](/filings/0001193125-26-145619.md) | [65.9](/filings/0001193125-26-292719.md) | [70.8 d](/filings/0001193125-26-431954.md) | [59.9](/filings/0001193125-26-007768.md) | [57.4](/filings/0001193125-26-145619.md) | [55.2](/filings/0001193125-26-292719.md) | [56.0 d](/filings/0001193125-26-431954.md) |
| Operating income | $m | [64.9](/filings/0000950170-25-003839.md) | [63.5](/filings/0000950170-25-052054.md) | [72.3](/filings/0000950170-25-092942.md) | [124 d](/filings/0001193125-26-431954.md) | [112](/filings/0001193125-26-007768.md) | [83.6](/filings/0001193125-26-145619.md) | [92.6](/filings/0001193125-26-292719.md) | [72.1 d](/filings/0001193125-26-431954.md) | [61.1](/filings/0001193125-26-007768.md) | [25.1](/filings/0001193125-26-145619.md) | [31.9](/filings/0001193125-26-292719.md) | [25.5 d](/filings/0001193125-26-431954.md) |
| Income tax | $m | [10.0](/filings/0000950170-25-003839.md) | [9.3](/filings/0000950170-25-052054.md) | [10.7](/filings/0000950170-25-092942.md) | [32.0 d](/filings/0001193125-26-431954.md) | [33.4](/filings/0001193125-26-007768.md) | [20.0](/filings/0001193125-26-145619.md) | [18.1](/filings/0001193125-26-292719.md) | [19.9 d](/filings/0001193125-26-431954.md) | [12.3](/filings/0001193125-26-007768.md) | [1.7](/filings/0001193125-26-145619.md) | [3.0](/filings/0001193125-26-292719.md) | [0.4 d](/filings/0001193125-26-431954.md) |
| Net income | $m | [31.2](/filings/0000950170-25-003839.md) | [33.4](/filings/0000950170-25-052054.md) | [33.9](/filings/0000950170-25-092942.md) | [61.6 d](/filings/0001193125-26-431954.md) | [55.3](/filings/0001193125-26-007768.md) | [51.9](/filings/0001193125-26-145619.md) | [60.1](/filings/0001193125-26-292719.md) | [36.8 d](/filings/0001193125-26-431954.md) | [36.4](/filings/0001193125-26-007768.md) | [15.0](/filings/0001193125-26-145619.md) | [18.9](/filings/0001193125-26-292719.md) | [8.7 d](/filings/0001193125-26-431954.md) |
| Diluted EPS | $ per share | [0.96](/filings/0000950170-25-003839.md) | [1.03](/filings/0000950170-25-052054.md) | [1.06](/filings/0000950170-25-092942.md) | not reported | [1.72](/filings/0001193125-26-007768.md) | [1.56](/filings/0001193125-26-145619.md) | [1.86](/filings/0001193125-26-292719.md) | not reported | [1.14](/filings/0001193125-26-007768.md) | [0.47](/filings/0001193125-26-145619.md) | [0.60](/filings/0001193125-26-292719.md) | not reported |
| Basic EPS | $ per share | [1.00](/filings/0000950170-25-003839.md) | [1.08](/filings/0000950170-25-052054.md) | [1.09](/filings/0000950170-25-092942.md) | not reported | [1.77](/filings/0001193125-26-007768.md) | [1.66](/filings/0001193125-26-145619.md) | [1.92](/filings/0001193125-26-292719.md) | not reported | [1.18](/filings/0001193125-26-007768.md) | [0.48](/filings/0001193125-26-145619.md) | [0.61](/filings/0001193125-26-292719.md) | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [307](/filings/0000950170-25-003839.md) | [252](/filings/0000950170-25-052054.md) | [272](/filings/0000950170-25-092942.md) | [352](/filings/0001193125-26-431954.md) | [300](/filings/0001193125-26-007768.md) | [264](/filings/0001193125-26-145619.md) | [297](/filings/0001193125-26-292719.md) | [306](/filings/0001193125-26-431954.md) | [362](/filings/0001193125-26-007768.md) | [522](/filings/0001193125-26-145619.md) | [274](/filings/0001193125-26-292719.md) | [235](/filings/0001193125-26-431954.md) |
| Total assets | $m | [4,015](/filings/0000950170-24-002449.md) | [4,044](/filings/0000950170-24-042261.md) | [4,116](/filings/0000950170-24-082097.md) | [4,255](/filings/0001193125-25-253612.md) | [4,288](/filings/0000950170-25-003839.md) | [4,267](/filings/0000950170-25-052054.md) | [4,353](/filings/0000950170-25-092942.md) | [4,361](/filings/0001193125-26-431954.md) | [4,296](/filings/0001193125-26-007768.md) | [4,340](/filings/0001193125-26-145619.md) | [4,348](/filings/0001193125-26-292719.md) | [4,434](/filings/0001193125-26-431954.md) |
| Long-term debt | $m | not reported | not reported | not reported | [1,756](/filings/0001193125-25-253612.md) | not reported | not reported | not reported | [1,751](/filings/0001193125-26-431954.md) | [1,766](/filings/0001193125-26-007768.md) | [1,763](/filings/0001193125-26-145619.md) | [1,806](/filings/0001193125-26-292719.md) | [1,837](/filings/0001193125-26-431954.md) |
| Shareholders' equity | $m | [1,274](/filings/0000950170-24-002449.md) | [1,300](/filings/0000950170-24-042261.md) | [1,329](/filings/0000950170-24-082097.md) | [1,376](/filings/0001193125-25-253612.md) | [1,413](/filings/0000950170-25-003839.md) | [1,460](/filings/0000950170-25-052054.md) | [1,504](/filings/0000950170-25-092942.md) | [1,533](/filings/0001193125-26-431954.md) | [1,542](/filings/0001193125-26-007768.md) | [1,565](/filings/0001193125-26-145619.md) | [1,573](/filings/0001193125-26-292719.md) | [1,574](/filings/0001193125-26-431954.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) | Q4 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(44.7)](/filings/0000950170-25-003839.md) | [99.1 d](/filings/0000950170-25-052054.md) | [84.0 d](/filings/0000950170-25-092942.md) | [191 d](/filings/0001193125-26-431954.md) | [(65.1)](/filings/0001193125-26-007768.md) | [93.6 d](/filings/0001193125-26-145619.md) | [139 d](/filings/0001193125-26-292719.md) | [98.0 d](/filings/0001193125-26-431954.md) | [76.2](/filings/0001193125-26-007768.md) | [159 d](/filings/0001193125-26-145619.md) | [(227) d](/filings/0001193125-26-292719.md) | [31.5 d](/filings/0001193125-26-431954.md) |
| Capital expenditure | $m | [68.3](/filings/0000950170-25-003839.md) | [122 d](/filings/0000950170-25-052054.md) | [134 d](/filings/0000950170-25-092942.md) | [73.6 d](/filings/0001193125-26-431954.md) | [59.1](/filings/0001193125-26-007768.md) | [67.3](/filings/0001193125-26-145619.md) | [82.7 d](/filings/0001193125-26-292719.md) | [71.3 d](/filings/0001193125-26-431954.md) | [57.5](/filings/0001193125-26-007768.md) | [30.1](/filings/0001193125-26-145619.md) | [59.6 d](/filings/0001193125-26-292719.md) | [132 d](/filings/0001193125-26-431954.md) |
| Dividends paid | $m | [10.3](/filings/0000950170-25-003839.md) | [9.4 d](/filings/0000950170-25-052054.md) | [9.4 d](/filings/0000950170-25-092942.md) | [9.3 d](/filings/0001193125-26-431954.md) | [10.4](/filings/0001193125-26-007768.md) | [9.4 d](/filings/0001193125-26-145619.md) | [9.9 d](/filings/0001193125-26-292719.md) | [9.9 d](/filings/0001193125-26-431954.md) | [1.7](/filings/0001193125-26-007768.md) | [19.8 d](/filings/0001193125-26-145619.md) | [10.5 d](/filings/0001193125-26-292719.md) | [10.6 d](/filings/0001193125-26-431954.md) |
| Share repurchases | $m | [1.3](/filings/0000950170-25-003839.md) | [0.0 d](/filings/0000950170-25-052054.md) | [0.0 d](/filings/0000950170-25-092942.md) | [0.0 d](/filings/0001193125-26-431954.md) | not reported | not reported | [21.8 d](/filings/0001193125-26-292719.md) | [0.9 d](/filings/0001193125-26-431954.md) | [12.9](/filings/0001193125-26-007768.md) | [0.4 d](/filings/0001193125-26-145619.md) | [0.0 d](/filings/0001193125-26-292719.md) | [0.1 d](/filings/0001193125-26-431954.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-30) | Q2 FY2023 (2023-02-28) | Q3 FY2023 (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [32.7](/filings/0000950170-24-002449.md) | [34.4](/filings/0000950170-24-042261.md) | [33.6](/filings/0000950170-24-082097.md) | [32.8](/filings/0000950170-25-003839.md) | [32.6](/filings/0000950170-25-052054.md) | [32.0](/filings/0000950170-25-092942.md) | [32.2](/filings/0001193125-26-007768.md) | [33.2](/filings/0001193125-26-145619.md) | [32.2](/filings/0001193125-26-292719.md) | [31.9](/filings/0001193125-26-007768.md) | [31.7](/filings/0001193125-26-145619.md) | [31.7](/filings/0001193125-26-292719.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 30,998,599 at 2026-10-20, from the cover of the [10-K filed 2026-10-26](/filings/0001193125-26-431954.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 18:28 ET. No prices; not investment advice.